HEPA Hepion Pharmaceuticals, Inc.
Healthcare$0.07-1.96%ClosedMarket Cap: $873,278
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.55
P/S
0.00
EV/EBITDA
0.53
DCF Value
$0.17
FCF Yield
-153.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-102.5%
ROA
-110.2%
ROIC
-186.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $-798.5K | $-810.8K | $— | — |
| Q4 null | $0.00 | NaN% | $-609.7K | $-656.9K | $— | — |
| FY null | $0.00 | NaN% | $-4.2M | $-8.3M | $— | — |
| Q3 null | $0.00 | NaN% | $-527.9K | $-472.5K | $— | — |
| Q2 null | $0.00 | NaN% | $-1.7M | $-1.0M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.3M | $-6.1M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.2M | $-1.5M | $— | — |
| FY null | $0.00 | NaN% | $-19.3M | $-13.2M | $— | — |
| Q3 null | $0.00 | NaN% | $-4.5M | $-4.9M | $— | — |
| Q2 null | $0.00 | NaN% | $-8.5M | $-3.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-5.2M | $-2.9M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-7.2M | $-11.1M | $-121.15 | — |